Hikal

Hikal is a leading CDMO designed to provide one-stop drug development and manufacturing services for antibodies and antibody–drug conjugates (ADCs). At Hikal, we specialize in small-molecule APIs, intermediates, and advanced intermediates, applying technologies such as hydrogenation, biocatalysis, and flow chemistry.

We have HPAPI capabilities up to OEB 5, enabling us to develop and manufacture ADC compounds. Our capabilities include payload and linker development, as well as ADC conjugation.